SciELO - Scientific Electronic Library Online

 
vol.36 issue8Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsisThe American-European Consensus Conference definition of the acute respiratory distress syndrome is dead, long live positive end-expiratory pressure! author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Medicina Intensiva

Print version ISSN 0210-5691

Abstract

CHAMORRO, C.  and  APARICIO, M.. Influence of HBcAb positivity in the organ donor in heart transplantation. Med. Intensiva [online]. 2012, vol.36, n.8, pp.563-570. ISSN 0210-5691.  https://dx.doi.org/10.1016/j.medin.2012.01.011.

Objective: There is a significant risk of hepatitis B transmission from HBsAg (-), HBcAb (+) donors in liver transplantation, but there is little information about hepatitis B transmission from HBcAb heart donors. The present study examines the influence of HBcAb presence in relation to heart donor acceptance and offers an update of the published studies. Design: Survey and medical database update from 1994 to October 2011. Setting: Spanish heart transplantation teams. Patients: Not applicable. Study variables: Acceptance of heart transplant from an HBcAb (+) organ donor. Results: Twelve out of 15 surveyed teams were seen to vaccinate against HBV, and two quantify HBsAb titers. Seven teams specifically request donor HBcAb status. If the latter proves positive, two do not accept transplantation, two accept if the donor is also HBsAb (+), one selects the receptor under emergency conditions, and three use drug prophylaxis isolatedly or complementary to the above. Only one case of hepatitis B has been reported in a HBcAb (-) and HBsAb (-) receptor that did not receive prophylactic measures. There have been reports of seroconversion of the HBcAb and HBsAb markers, though with an uncertain etiology. Conclusions: HBcAb seropositivity influences acceptance of a heart donor, but agreement is lacking. There is limited information on receptor evolution. To date there has been one reported case of hepatitis B after heart transplant. Although rare, an HBcAb (+) donor can harbor occult HBV infection. The risk of infection can be prevented with appropriate HBsAb titers following vaccination or by pharmacological measures.

Keywords : Organ donor; Anti-core; Heart transplant; Hepatitis B; Infection transmission; Donor selection.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License